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The Ongoing Natural Experiment of Cardiovascular Diseases in Japan Henry Blackburn, MD, and David R. Jacobs Jr., PhD
In this issue, Professor Shimamoto and the team of Japanese investigators working with Professor Komachi at Tsukuba University report dynamic trends in risk factor levels and cardiovascular disease (CVD) rates in rural Japan.' They postulate that rapid acculturation to Western and urban eating patterns and lifestyles, departing from traditions that are centuries old, is related to the major downward shift in average blood pressure and in stroke deaths between the 1960s and 1980s.
See p 503 They also consider that social changes resulted in a rise in average serum cholesterol level and, so far, a still low and stable incidence of coronary heart disease (CHD). Their findings suggest that an important "natural experiment" is taking place in Japan from which much may be learned about the causes and prevention of mass CVD.
The study design, as well as corroborative data from national surveys, provides confidence that the changes in risk factor levels in rural Japan are real. The authors also establish, among cohorts followed in the same region, a major decline in the incidence of stroke, especially cerebral hemorrhage. This, too, is confirmed by other surveys and national mortality data.2 They did not demonstrate trends in CHD incidence because there were too few cases. However, other reports from Japan suggest that while reported deaths from CHD decreased nationally until recently, CHD incidence is variable between populations and is probably increasing.3-6 These reports indicate a very sizable increase in coronary sudden deaths in some urban areas, as well as misclassifications of such deaths in Japan, which cause underestimates of CHD mortality. 4, 6 Less well documented here are apparently substantial changes in Japanese diet and lifestyle. Earlier rural and national surveys in Japan,57 when compared with these later findings, suggest strongly that major changes have occurred, resulting in increased consumption of total fat, saturated fatty acids and cholesterol, animal fats, and protein and decreased consumption of carbohydrates (primarily decreased rice consumption), as well as a generally decreased observance of the traditional diet (very high in salty foods and carbohydrates, relatively low in protein, and very low in fat).
We comment because of a long interest in the trends of CVD risk in Japan through involvement in the Seven Countries Study that first reported (in Western literature) the low frequency of CHD in Japan. 8 We comment also because we are impressed by these studies of risk and disease and by the dramatic trends demonstrated. Few examples exist of long-term, systematic, simultaneous observations, in the same population, of health behavior, risk factor levels, and disease incidence.9 Mainly, however, we comment on the authors' conclusions, particularly on their idea that an increased serum cholesterol level in the population contributes to the decline in risk of cerebral hemorrhage, and also on their explanation of why coronary artery disease rates may not yet have risen in Japan.
Despite the difficulty of relating population risk levels and disease, and their trends, such ecologic analyses may provide useful clues to population causes of CVD and its prevention when risk, behavior, and disease are all well measured, in parallel, and in the same population.9
Low Serum Cholesterol Levels and Stroke Risk Perhaps the most interesting and controversial conclusion by these authors, from their ecologic synthesis, is that the association between the rise in average blood cholesterol levels and the decline in stroke rates is a causal one, affecting in particular the population risk of cerebral hemorrhage. Supporting this idea is their finding of a more rapid decline in cerebral hemorrhage rates in the 1960s and 1970s during a period of more rapid increase in average cholesterol levels and lesser decline in mean blood pressure. They also find among the earlier of their 10-year cohorts, as do others studying Japanese populations,101l' a significant individual relation of low blood cholesterol levels and future stroke risk, particularly cerebral hemorrhage, independent of blood pressure level. Moreover, recent findings in a US population, among 350,000 MRFIT screenees followed 6 years, bear on this idea.'2 In that study, there was a sixfold excess risk of death from cerebral hemorrhage in middle- aged men having total serum cholesterol levels lower than 160 mg/dl and also elevated blood pressure (above 90 mm Hg diastolic). The inverse relation with cerebral hemorrhage disappeared above 160 mg/dl and in normotensives. There was, in contrast, a strong positive relation, starting at about 220 mg/ dl, between individual serum cholesterol level and future risk of death from cerebral infarction.
Many possible confounders remain in this relation, in particular, alcohol and aspirin intake, the presence of other bleeding disorders, liver disease, and other effects of a traditional Oriental diet (i.e., high salt, high carbohydrate, low fat, and low protein). One crucial "natural experiment," in addition, does not exist in Japan: What might be the population risk of cerebral hemorrhage in a hypothetical population consuming a diet low in saturated fatty acids, as in Japan, and with the consequent low serum cholesterol levels, but who also consumed little salt, much potassium, little alcohol, and adequate protein? A contrasting natural experiment in many Western societies is also relevant, where a high saturated fatty acid and cholesterol intake is accompanied by high salt, adequate protein, and low carbohydrate intake. In such populations, blood cholesterol and blood pressure levels are relatively high, as are the rates of all CVD, brain infarction, and cardiac infarction, while cerebral hemorrhage is clearly not absent.
In the Minnesota Heart Survey, this picture is also changing with time. 13 With simultaneous, long-term surveillance of health behaviors, risk factors and disease in the Twin Cities, we find that mean levels are declining for both blood pressure and serum total cholesterol, whereas deaths from CHD, cerebral infarction, and cerebral hemorrhage are falling in parallel. Thus, while the US natural experiment moves toward that of the Greeks and the Japanese, we are still seeing no increase in cerebral hemorrhage. This is consistent with either no relation to low cholesterol level or with a nonlinear relation. Still another combination of circumstances speaks against the hypothesis that low blood cholesterol is a primary cause of cerebral hemorrhage. That circumstance is in populations where both serum cholesterol and blood pressure averages are low and where the diet is traditionally Mediterranean (moderately high in fat from vegetable oils, adequate in protein, and intermediate in salt). Such populations uniformly have low rates for both CHD and all stroke.8 Thus, the hypothesis remains to be examined more fully whether low serum cholesterol levels, or individual or population factors related to low serum cholesterol levels, are causally related to cerebral hemorrhage and, if so, by what mechanisms.
We find, nevertheless, that this article by Shimamoto and colleagues crystallizes a wide difference in viewpoint between US and Japanese investigators. Many Japanese investigators have long accepted the notion of an inverse relation between serum cholesterol and hemorrhagic stroke, which is a major cause of death in their country. US inves-tigators, on the contrary, have long been skeptical of this possibility, supposing instead that there are few or no risks associated with low serum cholesterol levels and that the inverse relation with stroke in Japan is neither established nor causal.
We are now persuaded for several reasons that this difference in viewpoint should be resolved by further research. First, it is a reasonable principle that biologic attributes have an optimal range, with excess risk both for values too high and too low. We have recently and informally examined several sources of US and Japanese data along with their investigators. A review of published and unpublished data seems to substantiate an excess risk for hemorrhagic stroke in middle-aged men and women at the lowest levels of serum total cholesterol (i.e., <160 mg/dl) and an excess risk for other strokes, largely atherothrombotic in origin, at higher levels of serum cholesterol (i.e., >220 mg/dl). In addition, some of the mechanisms proposed by the Japanese for these differential relations appear plausible.
Accepting, then, that for individuals there is an inverse relationship of serum cholesterol level with cerebral hemorrhage, it is of great public health importance whether the risk attributable to low serum cholesterol is causal or due to confounding. If causal, does it require association with elevated blood pressure? Finally, is it the serum cholesterol level itself that is important or some factor that causes serum cholesterol to be low? If the inverse relation of serum cholesterol to cerebral hemorrhage were not substantiated by wider research, then one might suggest that the relation consistently observed by the Japanese is spurious or due to factors associated with low serum cholesterol in the Japanese setting. However, if the inverse relation were confirmed and consistent, then it would be important to investigate whether the relation is directly related to an effect of serum cholesterol or to factors that influence serum cholesterol.
We mention a pathologic study needed to examine a basic hypothesis of these Japanese investigators about the mechanism of stroke in relation to serum cholesterol.14 The hypothesis is that serum cholesterol-and presumably its LDL moietymust remain within certain limits to maintain optimal health of arterial walls, with very low levels resulting in damage of cell membranes in vessel walls and high levels resulting in atherosclerotic plaque. In studies of intracerebral arteries to test the hypothesis, we would expect to find thin cell walls, interrupted elastic membranes, and angionecrosis in patients who had low cholesterol levels, and atherosclerotic plaque in patients with high levels.
The pathology found should depend on the level of serum cholesterol in people who died of causes not related to CVD and be more pronounced in those who did die of CVD. Other studies are needed to include factors that influence coagulation, as well as alcohol intake, liver impairments, and the effects of other dietary factors on brain vessels.
Rising Cholesterol Levels and Low CHD Incidence
Finally, we address the apparent lack of correspondence between the rise in mean serum cholesterol levels in Japan and the apparently small change in CHD incidence, possibly even a decline in the already low level of CHD deaths. It seems to us likely, as the authors also suggest, that population exposure to elevated levels of atherogenic lipoproteins must be of sufficient magnitude and duration to result in mass atherosclerosis and to cause lesions sufficient to obstruct blood flow in many individuals. Coronary event rates in populations are clearly dependent on the underlying substrate of atherosclerosis in a population. Based on observations around the world, atherosclerotic disease is a major burden only in populations having relative mass hypercholesterolemia, that is, average cholesterol levels of 220 mg/dl and above. Population CHD rates are relatively high but quite variable in the range of 200-220 but are uniformly low where average population values are below 200 mg/ dl. 1 The Tsukuba investigators have established here that, in the early 1980s, total serum cholesterol levels in rural Japanese men reached an average around only 180 mg/dl and in women, 190 mg/dl, from a level around 150 mg/dl found 20 years before. Such a finding, in the presence of the well-documented fall in average blood pressure, is consistent with either no change, or an actual decline, in CHD incidence and death. We surmise, then, that neither the magnitude nor the duration of exposure to elevated atherogenic lipoproteins is as yet sufficient among the Japanese to be reflected in a major increase of coronary eyents. A decade or more at mean levels of 200 mg/dl and above is probably the required population exposure. The recent report cited from an urban population in Japan suggests that this effect may be happening; in some areas, sudden coronary death is increasing.4 By comparison, in the United States, 90% of total serum cholesterol values at the peak of our CHD epidemic in the 1960s exceeded the current Japanese mean, among rural men, of 180 mg/dl. Still today, more than 60% of adult US values exceed that level.
The causal mechanism proposed by our Japanese colleagues, that low serum cholesterol levels cause angionecrosis and weakening of small cerebral arteries and that raised serum total cholesterol levels prevent this arterial damage and therefore prevent stroke, remains, therefore, an interesting hyplothesis requiring more investigation. We estimate, nevertheless, if causation were eventually established, that the decreased Japanese risk of cerebral hemorrhage, attributable to a rise of average cholesterol values above 200 mg/dl, would almost certainly be greatly exceeded by the increased population risk of cerebral and myocardial infarction attributable to that rise. Conversely, we have considered elsewhere the implications of policy to lower the relatively high US serum cholesterol levels (mean, -210 mg/dl) by a reasonable goal, say, of 20 mg/dl, if the relations to serum cholesterol were inverse for cerebral hemorrhage and positive for brain and cardiac infarction.16 First, we considered that it should be possible to reduce any excess risk in the small subgroup having low blood cholesterol plus high blood pressure levels by systematic detection (i.e., cholesterol screening of hypertensives) and by control of their elevated blood pressure.
Second, we estimated that reduction in the risk of thrombotic stroke and CHD in the population due to reduced serum cholesterol levels would vastly counterbalance any remote, and still hypothetic, possibility that population risk of hemorrhagic stroke might rise.
